IL6 and breast carcinoma: For example, Bower et al. [47•] showed that a higher genetic risk index (i.e., presence of alleles associated with higher IL-1β, IL-6, and TNF-α expression) was associated with fatigue and memory complaints in breast cancer patients 3 months after primary treatment.